In outpatients with type 2 diabetes mellitus, persistent exenatide treatment lowered glycated hemoglobin and hyperglycemia in both genders. Waist circumference and body weight were more reduced in women.
Giancarla Meregalli, MD
Advertisement
Articles by Giancarla Meregalli, MD
Advertisement
Latest Updated Articles
- Potential Gender Differences of Exenatide in Outpatients With Type 2 Diabetes Mellitus
Published: September 24th 2015 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
December 2025 Product Updates
2
A Healthy Gut Could Improve Mental Health
3
Interview with Sa'ed al-Olimat, PharmD: How Pharmacists are Shaping the Future of Psychedelic Therapy
4
Reimagining Pharmacy: A Call to Action for Pharmacy Professionals
5